Callodine Capital Management’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.9M | Buy |
515,209
+109,240
| +27% | +$5.28M | 2.58% | 15 |
|
|
2025
Q1 | $22.5M | Buy |
405,969
+21,780
| +6% | +$1.21M | 3.75% | 10 |
|
|
2024
Q4 | $18.5M | Buy |
384,189
+20,000
| +5% | +$965K | 3.83% | 8 |
|
|
2024
Q3 | $21M | Sell |
364,189
-15,000
| -4% | -$864K | 4.38% | 8 |
|
|
2024
Q2 | $18.4M | Buy |
379,189
+10,000
| +3% | +$485K | 4.29% | 7 |
|
|
2024
Q1 | $17.9M | Buy |
369,189
+69,189
| +23% | +$3.36M | 4.34% | 8 |
|
|
2023
Q4 | $14.9M | Buy |
300,000
+55,000
| +22% | +$2.74M | 3.93% | 9 |
|
|
2023
Q3 | $13.1M | Sell |
245,000
-15,000
| -6% | -$805K | 3.66% | 10 |
|
|
2023
Q2 | $14M | Sell |
260,000
-85,000
| -25% | -$4.58M | 4.02% | 10 |
|
|
2023
Q1 | $18.8M | Sell |
345,000
-5,000
| -1% | -$272K | 5.54% | 6 |
|
|
2022
Q4 | $17M | Buy |
350,000
+50,000
| +17% | +$2.42M | 5.05% | 7 |
|
|
2022
Q3 | $11.4M | Buy |
300,000
+133,065
| +80% | +$5.06M | 3.55% | 12 |
|
|
2022
Q2 | $8.35M | Buy |
+166,935
| New | +$8.35M | 2.47% | 20 |
|